Vol 2, No 1 (2013)
Review article
Published online: 2013-04-10
Page views
654
Article views/downloads
6496
Treatment of dyslipidemia in diabetes — individualization of therapeutic strategies
Diabetologia Kliniczna 2013;2(1):23-29.
Abstract
In this paper treatment recommendations of diabetic
dyslipidemia are presented, based on PTD guidelines.
The goal of treatment in patients with diabetes
is to decrease LDL-cholesterol level below 2.6 mmol/l
and in patients with diabetes and cardiovascular
disease below 1.8 mmol/l. Desirable values of HDL-C
is > 1.3 mmol/l in women and > 1.0 mmol/l in men,
and of triglycerides < 1.7 mmol/l. Statin is fi rst line
treatment; if targets are not reached combined therapy
with other lipid lowering drugs may be considered, but
this therapy has not been evaluated in CVD and safety
outcome studies.
dyslipidemia are presented, based on PTD guidelines.
The goal of treatment in patients with diabetes
is to decrease LDL-cholesterol level below 2.6 mmol/l
and in patients with diabetes and cardiovascular
disease below 1.8 mmol/l. Desirable values of HDL-C
is > 1.3 mmol/l in women and > 1.0 mmol/l in men,
and of triglycerides < 1.7 mmol/l. Statin is fi rst line
treatment; if targets are not reached combined therapy
with other lipid lowering drugs may be considered, but
this therapy has not been evaluated in CVD and safety
outcome studies.
Keywords: diabetic dyslipidemiadiabetesstatins